FDA warning letters
A warning letter is FDA's formal notice that a company broke the law, usually found during an inspection. The company has 15 working days to reply. Letters that go unanswered lead to seizures, import bans or court orders.
9 letters match. Newest first.
-
AnimalSciarra Aeromed, Inc.
Sciarra Aeromed's purportedly sterile veterinary drug was contaminated and made under insanitary conditions, FDA says.
High risk -
DrugsABS Corporation
ABS Corporation released out-of-specification veterinary drugs and used inadequately tested raw materials, FDA says.
High risk -
AnimalElanco Animal Health USA
FDA says Elanco's Pradalex ads misbrand the livestock antibiotic by claiming first-line use and "all relevant pathogen" coverage.
Medium -
AnimalAurora Pharmaceutical
FDA told Aurora Pharmaceutical its websites and brochures for three animal drugs hid safety warnings, making the products misbranded.
Medium -
AnimalNutrition Strength Ltd.
FDA warns Nutrition Strength Ltd. over unapproved dog seizure and blood-support supplements marketed as animal drugs.
High risk -
Animaltotaltoltrazuril.com
FDA warned totaltoltrazuril.com for selling Total Toltrazuril, an unapproved new animal drug, for coccidiosis and horse EPM.
High risk -
AnimalBoehringer Ingelheim Animal Health USA
FDA warned Boehringer Ingelheim Animal Health USA that Senvelgo promotional materials falsely claimed safety and effectiveness in previously insulin-treated cats.
High risk -
AnimalEquine Podiatry Solutions, LLC
Equine Podiatry Solutions marketed Desmosphyrine, an unapproved new animal drug, for treating laminitis in horses.
High risk -
AnimalGroupe Cyrenne Inc. dba HomeoAnimal
FDA warned HomeoAnimal that it sells unapproved animal drugs with claims to treat cancer, heartworm, seizures, and COVID-19 in animals.
High risk